The Non-Vascular Stents Market is expected to grow at a CAGR of 4.5% over the forecast period. (2022 - 2032). The sector is expected to be valued at US$ 1.21 billion in 2022 and US$ 1.9 billion by 2032.
The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth.
Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital stay for the patient, encouraging many to opt for the same.
Request Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-653
Furthermore, patients are less likely to contract hospital-acquired illnesses like bloodstream infections and urinary tract infections if they stay in the hospital for a shorter period of time, in turn, propelling the demand for non-vascular stents.
The most visible and prominent factor spiking the sales of non-vascular stents is a surge in cases of chronic obstructive pulmonary disease (COPD), which is caused by smoking, lung cancer, tracheobronchial malacia, and chemical exposure.
Based on product type, the urological stents segment is likely to dominate the non-vascular stents market with a CAGR of 4.3% through 2032.
The US non-vascular stents market is expected to capture a sizeable non-vascular stents market share accounting for around US$659.1 million by 2032.
By 2032, the UK non-vascular stents market is expected to be valued at US$ 80.6 million, growing at a CAGR of 3.3%.
With a CAGR of 3.6% during the forecast period, China non-vascular stents market size is predicted to be apprised at US$ 128.1 million by 2032.
The Japan non-vascular stents market, with a CAGR of 3.9%, is projected to garner a worth of US$ 109.8 million by 2032.
- Some of the leading non-vascular stents companies include Medtronic plc, Glaukos Corporation, Boston Scientific Corporation, ELLA - CS, s.r.o., CONMED Corporation.
- One of the recent developments in the non-vascular stents market is when Medtronic acquired Medicrea, a fully dedicated spinal implant company focused on bringing reliable and cutting-edge technology to the global market.
- Medtronic plc.
- Glaukos Corporation
- Boston Scientific Corporation
- ELLA - CS, s.r.o.
- CONMED Corporation
- Gastrointestinal Stents
- Oesophageal Stents
- Pulmonary Stents
- Silicone Airway
- Metallic Airway
- Urological Stents